LSD
Cannabis Coalition Forms To Push Biden On Federal Reform: Will It Work This Time?
Marijuana organizations, industry leaders, cannabis companies and experts in the field are teaming up to push for cannabis reform on the federal level….
Marijuana organizations, industry leaders, cannabis companies and experts in the field are teaming up to push for cannabis reform on the federal level.
Last October President Biden asked the attorney general and Department of Health and Human Service to review cannabis classification under federal law as a Schedule 1 drug, the same classification as heroin and LSD. The move came as part of another important marijuana announcement – Biden’s pardon of all prior federal offenses of simple cannabis possession.
Then in December, Biden officially signed a marijuana research bill into law, making history by enacting the first piece of standalone federal cannabis reform legislation in U.S. history,
Now, as the Biden Administration is actively reviewing cannabis classification, this diverse group is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform (CCSR), which will engage with stakeholders in the ...
Full story available on Benzinga.com
lsd-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID